Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Rapid-acting insulin formulation comprising a substituted anionic compound

Rapid-acting insulin formulation comprising a substituted anionic compound

US Patent 10583175 · Granted Mar 10, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hydrogels for cell therapy2025
Compositions in the form of an injectable aqueous solution comprising amylin, an2025
Injectable pH 7 solution comprising at least one basal insulin having a pI from 2024
Injectable solution at pH 7 comprising at least one basal insulin wherein the pI2023
Injectable solution at pH 7 comprising at least one basal insulin for which the 2023
Rapid-acting insulin formulation comprising a substituted anionic compound2022
Compositions in the form of an injectable aqueous solution comprising human gluc2021
Compositions in the form of an injectable aqueous solution comprising amylin, an2021
Compositions in the form of an injectable aqueous solution comprising amylin, an2021
Compositions in the form of an injectable aqueous solution comprising human gluc2021
Rapid-acting insulin formulation comprising a substituted anionic compound2021
Rapid-acting insulin composition comprising a substituted citrate2020